Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

American Journal of Public Health, Vol. 86, Issue 5 655-661, Copyright © 1996 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (352)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garfein, R S
Right arrow Articles by Nelson, K E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garfein, R S
Right arrow Articles by Nelson, K E
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

R S Garfein, D Vlahov, N Galai, M C Doherty and K E Nelson

Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Md 21205, USA.

OBJECTIVES: The purpose of this study was to estimate the prevalence and correlates of four blood-borne viral infections among illicit drug injectors with up to 6 years of injecting experience. METHODS: We analyzed data from 716 volunteers recruited in 1988 and 1989. Test results for hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus, type 1 (HIV), and human T-lymphotropic virus types I and II (HTLV) were examined across six sequential cohorts defined by duration of drug injection. RESULTS: Overall, seroprevalence of HCV, HBV, HIV, and HTLV was 76.9%, 65.7%, 20.5% and 1.8%, respectively, and 64.7%, 49.8%, 13.9%, and 0.5%, respectively, among those who had injected for 1 year or less. Among the newest initiates, HCV and HBV were associated with injecting variables, and HIV was associated with sexual variables. CONCLUSIONS: The high rates of HCV, HBV, and HIV infections among short-term injectors emphasizes the need to target both parenteral and sexual risk reduction interventions early. Renewed efforts at primary prevention of substance abuse are indicated.




This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
H. Hagan, E. R. Pouget, D. C. Des Jarlais, and C. Lelutiu-Weinberger
Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place
Am. J. Epidemiol., November 15, 2008; 168(10): 1099 - 1109.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. A. Fiellin
Treatment of Adolescent Opioid Dependence: No Quick Fix
JAMA, November 5, 2008; 300(17): 2057 - 2059.
[Full Text] [PDF]

Home page
 JAMAHome page
Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Users--New York, November 2004-April 2007
JAMA, July 2, 2008; 300(1): 34 - 36.
[Full Text] [PDF]

Home page
 Epidemiol RevHome page
C. W. Shepard, E. P. Simard, L. Finelli, A. E. Fiore, and B. P. Bell
Hepatitis B Virus Infection: Epidemiology and Vaccination
Epidemiol. Rev., August 1, 2006; 28(1): 112 - 125.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. A. Jaffe and P. L. Kimmel
Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 655 - 667.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
K. McNelis
Management of Hepatitis C Infection in the HIV-Infected Patient
Journal of Pharmacy Practice, February 1, 2006; 19(1): 37 - 52.
[Abstract] [PDF]

Home page
 Postgrad. Med. J.Home page
V Lo Re III and J R Kostman
Management of chronic hepatitis C
Postgrad. Med. J., June 1, 2005; 81(956): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
C. M. Fuller, L. N. Borrell, C. A. Latkin, S. Galea, D. C. Ompad, S. A. Strathdee, and D. Vlahov
Effects of Race, Neighborhood, and Social Network on Age at Initiation of Injection Drug Use
Am J Public Health, April 1, 2005; 95(4): 689 - 695.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
D. C. Ompad, R. M. Ikeda, N. Shah, C. M. Fuller, S. Bailey, E. Morse, P. Kerndt, C. Maslow, Y. Wu, D. Vlahov, et al.
Childhood Sexual Abuse and Age at Initiation of Injection Drug Use
Am J Public Health, April 1, 2005; 95(4): 703 - 709.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S M Alavian and B Hajarizadeh
Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs
Gut, July 1, 2004; 53(7): 1057 - 1057.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
C. U. Onyike, J. O. Bonner, C. G. Lyketsos, and G. J. Treisman
Mania During Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin
Am J Psychiatry, March 1, 2004; 161(3): 429 - 435.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. J. Krantz and P. S. Mehler
Treating Opioid Dependence: Growing Implications for Primary Care
Arch Intern Med, February 9, 2004; 164(3): 277 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
R. J Garten, S. Lai, J. Zhang, W. Liu, J. Chen, D. Vlahov, and X.-F. Yu
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China
Int. J. Epidemiol., February 1, 2004; 33(1): 182 - 188.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
A. Krain, J. P. Wisnivesky, E. Garland, and T. McGinn
Prevalence of Human Immunodeficiency Virus Testing in Patients With Hepatitis B and C Infection
Mayo Clin. Proc., January 1, 2004; 79(1): 51 - 56.
[Abstract] [PDF]

Home page
 Int J EpidemiolHome page
M. Zwahlen and D. Vlahov
Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users
Int. J. Epidemiol., October 1, 2003; 32(5): 715 - 716.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. Dong, S. R. Dube, V. J. Felitti, W. H. Giles, and R. F. Anda
Adverse Childhood Experiences and Self-reported Liver Disease: New Insights Into the Causal Pathway
Arch Intern Med, September 8, 2003; 163(16): 1949 - 1956.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
F. C. Osher, R. W. Goldberg, S. W. McNary, M. S. Swartz, S. M. Essock, M. I. Butterfield, S. D. Rosenberg, and the Five-Site Health and Risk Study Research Commi
Blood-Borne Infections and Persons With Mental Illness: Substance Abuse and the Transmission of Hepatitis C Among Persons With Severe Mental Illness
Psychiatr Serv, June 1, 2003; 54(6): 842 - 847.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
P. J. Lum, K. C. Ochoa, J. A. Hahn, K. Page Shafer, J. L. Evans, and A. R. Moss
Hepatitis B Virus Immunization Among Young Injection Drug Users in San Francisco, Calif: The UFO Study
Am J Public Health, June 1, 2003; 93(6): 919 - 923.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. H. Kral, J. Lorvick, L. Gee, P. Bacchetti, B. Rawal, M. Busch, and B. R. Edlin
Trends in Human Immunodeficiency Virus Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987-1998
Am. J. Epidemiol., May 15, 2003; 157(10): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
D. C. Des Jarlais, T. Diaz, T. Perlis, D. Vlahov, C. Maslow, M. Latka, R. Rockwell, V. Edwards, S. R. Friedman, E. Monterroso, et al.
Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City
Am. J. Epidemiol., March 1, 2003; 157(5): 467 - 471.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. A. MARX, K. G. MURUGAVEL, S. SIVARAM, P. BALAKRISHNAN, M. STEINHOFF, S. ANAND, D. L. THOMAS, S. SOLOMON, and D. D. CELENTANO
THE ASSOCIATION OF HEALTH-CARE USE AND HEPATITIS C VIRUS INFECTION IN A RANDOM SAMPLE OF URBAN SLUM COMMUNITY RESIDENTS IN SOUTHERN INDIA
Am J Trop Med Hyg, February 1, 2003; 68(2): 258 - 262.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. F. Murray, L. P. Richardson, C. Morishima, J. W. M. Owens, and D. R. Gretch
Prevalence of Hepatitis C Virus Infection and Risk Factors in an Incarcerated Juvenile Population: A Pilot Study
Pediatrics, January 1, 2003; 111(1): 153 - 157.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. Jagger, V. Puro, G. De Carli, A. J. Lunsk, M. S. Sulkowsky, S. C. Ray, and D. L. Thomas
Occupational Transmission of Hepatitis C Virus
JAMA, September 25, 2002; 288(12): 1469 - 1471.
[Full Text] [PDF]

Home page
 AJPHHome page
C.-C. N. U. Pratt, D. Paone, R. J. Carter, and M. C. Layton
Hepatitis C Screening and Management Practices: A Survey of Drug Treatment and Syringe Exchange Programs in New York City
Am J Public Health, August 1, 2002; 92(8): 1254 - 1256.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. K. Herrine
Approach to the Patient with Chronic Hepatitis C Virus Infection
Ann Intern Med, May 21, 2002; 136(10): 747 - 757.
[Abstract] [Full Text] [PDF]

Home page
 AIDS Clin CareHome page
Diagnosis and Management of the HCV/HIV-Coinfected Patient
AIDS Clinical Care, May 1, 2002; 2002(501): 1 - 1.
[Full Text]

Home page
 Am J EpidemiolHome page
L. E Thorpe, L. J Ouellet, R. Hershow, S. L Bailey, I. T Williams, J. Williamson, E. R Monterroso, and R. S Garfein
Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment
Am. J. Epidemiol., April 1, 2002; 155(7): 645 - 653.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
C. S. Murrill, H. Weeks, B. C. Castrucci, H. S. Weinstock, B. P. Bell, C. Spruill, and M. Gwinn
Age-Specific Seroprevalence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infection Among Injection Drug Users Admitted to Drug Treatment in 6 US Cities
Am J Public Health, March 1, 2002; 92(3): 385 - 387.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
D. M. Patrick, M. W. Tyndall, P. G.A. Cornelisse, K. Li, C. H. Sherlock, M. L. Rekart, S. A. Strathdee, S. L. Currie, {d.{d. Schechter, and M. V. O'Shaughnessy
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
Can. Med. Assoc. J., October 1, 2001; 165(7): 889 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
H. A. Pollack
Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users
Med Decis Making, October 1, 2001; 21(5): 357 - 367.
[Abstract] [PDF]

Home page
 NEJMHome page
G. L. Davis and J. R. Rodrigue
Treatment of Chronic Hepatitis C in Active Drug Users
N. Engl. J. Med., July 19, 2001; 345(3): 215 - 217.
[Full Text] [PDF]

Home page
 ScienceHome page
O. G. Pybus, M. A. Charleston, S. Gupta, A. Rambaut, E. C. Holmes, and P. H. Harvey
The Epidemic Behavior of the Hepatitis C Virus
Science, June 22, 2001; 292(5525): 2323 - 2325.
[Abstract] [Full Text] [PDF]

Home page
 J. Epidemiol. Community HealthHome page
E J C van Ameijden and R A Coutinho
Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions
J Epidemiol Community Health, May 1, 2001; 55(5): 356 - 363.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
Y.-W. Hu, E. Balaskas, M. Furione, P.-H. Yen, G. Kessler, V. Scalia, L. Chui, and G. Sher
Comparison and Application of a Novel Genotyping Method, Semiautomated Primer-Specific and Mispair Extension Analysis, and Four Other Genotyping Assays for Detection of Hepatitis C Virus Mixed-Genotype Infections
J. Clin. Microbiol., August 1, 2000; 38(8): 2807 - 2813.
[Abstract] [Full Text]

Home page
 JAMAHome page
D. L. Thomas, J. Astemborski, R. M. Rai, F. A. Anania, M. Schaeffer, N. Galai, K. Nolt, K. E. Nelson, S. A. Strathdee, L. Johnson, et al.
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
JAMA, July 26, 2000; 284(4): 450 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
Y. J. F. Hutin, K. M. Sabin, L. C. Hutwagner, L. Schaben, G. M. Shipp, D. M. Lord, J. S. Conner, M. P. Quinlisk, C. N. Shapiro, and B. P. Bell
Multiple Modes of Hepatitis A Virus Transmission among Methamphetamine Users
Am. J. Epidemiol., July 15, 2000; 152(2): 186 - 192.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J.-T. CHENG, H. L. ANDERSON, G. S. MARKOWITZ, G. B. APPEL, V. A. POGUE, and V. D. D'AGATI
Hepatitis C Virus-Associated Glomerular Disease in Patients with Human Immunodeficiency Virus Coinfection
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1566 - 1574.
[Abstract] [Full Text]

Home page
 ANN INTERN MEDHome page
B. Kane
Controlling Disease Transmission in Injection Drug Users
Ann Intern Med, March 16, 1999; 130(6): 541 - 544.
[Full Text]

Home page
 QJMHome page
S.M. Gore, A.G. Bird, S.O. Cameron, S.J. Hutchinson, S.M. Burns, and D.J. Goldberg
Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours
QJM, January 1, 1999; 92(1): 25 - 32.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
N. Gunn, C. White, and R. Srinivasan
Primary Care as Harm Reduction for Injection Drug Users
JAMA, October 7, 1998; 280(13): 1191 - 1195.
[Full Text] [PDF]

Home page
 JAMAHome page
Update: Syringe-Exchange Programs--United States, 1996
JAMA, July 16, 1997; 278(3): 197 - 198.
[Abstract] [PDF]

Home page
 Criminal Justice and BehaviorHome page
R. F. SCHILLING, A. IVANOFF, N. EL-BASSEL, and F. SOFFA
HIV-Related Behaviors in Transitional Correctional Settings
Criminal Justice and Behavior, June 1, 1997; 24(2): 256 - 277.
[Abstract]

Home page
 JAMAHome page
L. O. Gostin, Z. Lazzarini, T. S. Jones, and K. Flaherty
Prevention of HIV/AIDS and Other Blood-Borne Diseases Among Injection Drug Users: A National Survey on the Regulation of Syringes and Needles
JAMA, January 1, 1997; 277(1): 53 - 62.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Public Health Association